FSA Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
1,151
-57
| -5% | -$10.6K | 0.08% | 52 |
|
|
2025
Q1 | $253K | Sell |
1,208
-38
| -3% | -$7.96K | 0.11% | 47 |
|
|
2024
Q4 | $221K | Buy |
1,246
+4
| +0.3% | +$711 | 0.09% | 49 |
|
|
2024
Q3 | $245K | Buy |
+1,242
| New | +$245K | 0.1% | 47 |
|
|
2024
Q1 | $243K | Buy |
1,333
+173
| +15% | +$31.5K | 0.11% | 45 |
|
|
2023
Q4 | $180K | Buy |
+1,160
| New | +$180K | 0.09% | 53 |
|
|
2021
Q1 | – | Sell |
-1,516
| Closed | -$162K | – | 47 |
|
|
2020
Q4 | $162K | Buy |
+1,516
| New | +$162K | 0.08% | 61 |
|
|
2020
Q3 | – | Sell |
-1,716
| Closed | -$168K | – | 56 |
|
|
2020
Q2 | $168K | Buy |
1,716
+32
| +2% | +$3.13K | 0.11% | 59 |
|
|
2020
Q1 | $128K | Buy |
1,684
+60
| +4% | +$4.56K | 0.11% | 67 |
|
|
2019
Q4 | $144K | Buy |
+1,624
| New | +$144K | 0.1% | 72 |
|